chr12-7814324-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001286234.2(SLC2A14):āc.1486A>Gā(p.Asn496Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000218 in 1,602,370 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001286234.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC2A14 | NM_001286234.2 | c.1486A>G | p.Asn496Asp | missense_variant | 11/11 | ENST00000431042.7 | NP_001273163.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC2A14 | ENST00000431042.7 | c.1486A>G | p.Asn496Asp | missense_variant | 11/11 | 1 | NM_001286234.2 | ENSP00000407287.2 |
Frequencies
GnomAD3 genomes AF: 0.0000137 AC: 2AN: 146000Hom.: 0 Cov.: 25
GnomAD3 exomes AF: 0.0000162 AC: 4AN: 246966Hom.: 0 AF XY: 0.0000299 AC XY: 4AN XY: 133592
GnomAD4 exome AF: 0.0000227 AC: 33AN: 1456370Hom.: 0 Cov.: 36 AF XY: 0.0000262 AC XY: 19AN XY: 723994
GnomAD4 genome AF: 0.0000137 AC: 2AN: 146000Hom.: 0 Cov.: 25 AF XY: 0.0000141 AC XY: 1AN XY: 70792
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 25, 2024 | The c.1555A>G (p.N519D) alteration is located in exon 12 (coding exon 10) of the SLC2A14 gene. This alteration results from a A to G substitution at nucleotide position 1555, causing the asparagine (N) at amino acid position 519 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at